ライフサイエンスコーパス: pelvic

1 onographic short cervix (</=15 mm) underwent pelvic 1.5-T magnetic resonance (MR) imaging.

2 eased risk of LN involvement (LNI) underwent pelvic (99m)Tc-trofolastat SPECT/CT before radical prost

3 erative days, including anastomotic leakage, pelvic abscess, and peritonitis.

4 and seven in group 4); the most common were pelvic abscesses (seven patients) and anastomotic leaks

5 nd general knowledge of the lumbar spine and pelvic anatomy relevant to the child in their evaluation

6 Patients underwent PET/CT and pelvic and abdominal lymphadenectomy.

7 atobium-endemic area in Madagascar underwent pelvic and colposcopic examinations.

8 pelvic and lower limb muscle MRI scans of 269 symptomati

9 ancer of the bladder (UBC) metastatic to the pelvic and retroperitoneal lymph nodes was treated with

10 repeat imaging studies revealed progressive pelvic and retroperitoneal lymphadenopathy, and the pati

11 lly in the thoracic spine and thoracic wall, pelvic and shoulder girdles, and peripheral entheses and

12 5 at the abdominal level, in 13 at both the pelvic and the abdominal level, and in 46 at the abdomin

13 ic findings were consistent with correlative pelvic angiograms in all 16 patients for whom the latter

14 ings at FE MR angiography were compared with pelvic angiograms.

15 ological similarity between the pectoral and pelvic appendages within each taxon.

16 normal fetal development, it remains in the pelvic area and is called a pelvic kidney.

17 Pelvic arteriovenous malformations (AVMs) are uncommon l

18 t the imaging findings of a giant congenital pelvic AVM that was diagnosed in a 30-year-old male pati

19 Pelvic AVMs are uncommon lesions and they can present wi

20 In all other fishes, the pelvic bones are suspended in a muscular sling or loosel

21 ogression from the site of the lesion to the pelvic bones.

22 he mass had vertebral organization, limb and pelvic bones.

23 Overall, the pelvises had features of female pelvic bony structure although pelvic diameters were som

24 onal selection for a large neonate, a narrow pelvic canal, or both is sufficient to account for the c

25 east cancer, 37% for melanoma, and 65.6% for pelvic cancer.

26 pooled trial cohort of > 2,500 patients with pelvic cancers, those who underwent EBRT or VBT had no h

27 st cancer, 11.1% for melanoma, and 51.6% for pelvic cancers.

28 ic radiotherapy is an important treatment of pelvic cancers.

29 Two large omental cysts were found in the pelvic cavity along with torsed greater omentum along wi

30 Failure to recognize pelvic compensation can lead to under-treatment and poor

31 C) include a 1-year post-resection abdominal-pelvic computed tomography (CT) scan and optical colonos

32 ogical and hepato-renal parameters, abdomino-pelvic CT and a CT-guided biopsy.

33 ong 42 111 women who underwent abdominal and pelvic CT examinations in the study period, 2763 (6.6%;

34 onal database was searched for abdominal and pelvic CT studies performed between June 2003 and Decemb

35 The evidence that hormones mediate female pelvic development and morphology supports the view that

36 From 40 y onward females resume a mode of pelvic development similar to males, resulting in signif

37 res of female pelvic bony structure although pelvic diameters were somewhat lower in multiparous wome

38 was in accordance with their somewhat lower pelvic diameters.

39 ssed retrospectively the reference values of pelvic dimensions by 3D CT performed for non-obstetrical

40 disproportion of fetal size and the mother's pelvic dimensions has puzzled evolutionary scientists fo

41 in rapid expansion of obstetrically relevant pelvic dimensions up to the age of 25-30 y.

42 apeutic target in cases of radiation-induced pelvic disease.

43 th improved visualization and ergonomics for pelvic dissection.

44 technique pioneered to facilitate difficult pelvic dissections.

45 randomized trial suggests that the use of a pelvic drain after rectal excision for rectal cancer did

46 To assess the effect of pelvic drainage after rectal surgery for cancer.

47 tified for overall benefits and harms of the pelvic examination as a 1-time or periodic screening tes

48 on screening for gynecologic conditions with pelvic examination for conditions other than cervical ca

49 nefits, accuracy, and harms of the screening pelvic examination for gynecologic conditions for the US

50 y rates resulting from an abnormal screening pelvic examination for ovarian cancer ranged from 5% to

51 on screening for pathologic conditions using pelvic examination in adult, asymptomatic women at avera

52 No trials examined the effectiveness of the pelvic examination in reducing all-cause mortality, redu

53 Although the pelvic examination is a common part of the physical exam

54 mplication rate within 1 year of a screening pelvic examination with abnormal findings.

55 dees at 2 Provincial STI clinics receiving a pelvic examination, regardless of a history of anal inte

56 pinion recommends in favor of routine annual pelvic examination.

57 t women's health are often evaluated through pelvic examination.

58 studies reported accuracy for the screening pelvic examination: ovarian cancer (4 studies; n = 26432

59 led to questions about the role of screening pelvic examinations among asymptomatic women.

60 SPSTF found inadequate evidence on screening pelvic examinations for the early detection and treatmen

61 r women need to be seen annually for routine pelvic examinations has arisen.

62 Pelvic examinations have historically been a part of reg

63 stic accuracy and harms of routine screening pelvic examinations in asymptomatic primary care populat

64 , it is unclear whether performing screening pelvic examinations in asymptomatic women has a signific

65 f benefits and harms of performing screening pelvic examinations in asymptomatic, nonpregnant adult w

66 and potential harms of performing screening pelvic examinations in asymptomatic, nonpregnant adult w

67 in high-risk women such as those undergoing pelvic exams at STI clinics.

68 ; HR 3.70, P < 0.01, respectively] and after pelvic exenteration (HR 2.23, P < 0.01; HR 2.93, P < 0.0

69 survival after abdominoperineal excision and pelvic exenteration for primary or recurrent rectal canc

70 r advanced anterior rectal cancer, posterior pelvic exenteration instead of abdominoperineal excision

71 For appropriately selected patients, pelvic exenteration surgery can achieve long-term diseas

72 databases of 5 high volume institutions for pelvic exenteration surgery were reviewed and data combi

73 noperineal excision were 14.7% and 24.0% for pelvic exenteration.

74 studies reporting on 1326 participants after pelvic exenteration.

75 in the urinary tract, thus allowing thorough pelvic exploration.

76 Periprostatic and pelvic fat have been shown to influence prostate cancer

77 h closer to the renal capsule than the renal pelvic fat.

78 ossess claspers, which extend from posterior pelvic fins and function as intromittent organs.

79 controls the male-specific pattern of Shh in pelvic fins by regulation of Hand2.

80 rity of gene expression between pectoral and pelvic fins has been documented in chondrichthyans, but

81 rported serial homologues, and the advent of pelvic fins has been hypothesized to have resulted from

82 two sets of paired appendages, pectoral and pelvic fins in fishes and fore- and hindlimbs in tetrapo

83 of chondrification between the pectoral and pelvic fins was found, which could be interpretated as f

84 ding an elongated axis and the loss of ribs, pelvic fins, and teeth.

85 Pelvic floor biofeedback therapy is effective for treati

86 bdominal pain, sphincter of Oddi dyskinesia, pelvic floor dysfunction, and extra-intestinal manifesta

87 tive treatments (such as dietary changes and pelvic floor exercises) had not worked, were randomly as

88 Women from a longitudinal study of pelvic floor function after childbirth were potentially

89 uggested that biological mesh closure of the pelvic floor improves perineal wound healing.

90 a common childhood problem often related to pelvic floor muscle dysfunction.

91 a common childhood problem often related to pelvic floor muscle dysfunction.

92 ter allocation, to receive either one-to-one pelvic floor muscle training (five physiotherapy appoint

93 Pelvic floor muscle training can reduce prolapse severit

94 weeks, and annual review) plus Pilates-based pelvic floor muscle training classes and a DVD for home

95 Our study shows that pelvic floor muscle training leads to a small, but proba

96 INTERPRETATION: Our study shows that pelvic floor muscle training leads to a small, but proba

97 ll as diaphragm, intercostal, abdominal, and pelvic floor muscles.

98 uently prescribed in IBS-C, prucalopride and pelvic floor rehabilitation in FC.

99 st prescribed laxative, and prucalopride and pelvic floor rehabilitation represented a "second line"

100 ine acellular dermal mesh was sutured to the pelvic floor remnants in the intervention arm, followed

101 d imaging are useful for evaluating anal and pelvic floor structure and function.

102 organs of the female reproductive tract and pelvic floor undergo significant remodeling and alterati

103 ss than 8 (OR, 2.75; 95% CI, 1.53-4.94), and pelvic fracture (OR, 2.09; 95% CI, 1.23-3.55) predicted

104 is, venous injury, lower extremity fracture, pelvic fracture, central line, intracranial hemorrhage,

105 than 2 hours (35.6% vs 16.4%; P < .001), and pelvic fractures (43.8% vs 21.4%; P < .001); patients wi

106 tic afferents to study micturition and other pelvic functions.

107 Pelvic ganglia neural cell bodies contained heparanase 1

108 parasympathetic, as are their targets in the pelvic ganglia that prominently control rectal, bladder,

109 nd caspase-3 mediated apoptosis in the major pelvic ganglion (MPG).

110 and step length through the rotation of the pelvic girdle and retraction of the femur.

111 In contrast, the pelvic girdle of Cryptotora is a large, broad puboischia

112 teral sequence gait and has evolved a robust pelvic girdle that shares morphological features associa

113 mbless, basal and intermediate snakes retain pelvic girdles and small rudiments of the femur.

114 accomplished by rotation of the pectoral and pelvic girdles creating a standing wave of the axial bod

115 atory disease that affects the shoulder, the pelvic girdles, and the neck, usually in individuals old

116 ssed SNs during surgery, but with respect to pelvic hotspots, in most cases they are more probably re

117 ither on account of a negative biopsy or had pelvic imaging done for a non-prostate malignancy.

118 ts with the GI panel had 0.18 abdomen and/or pelvic imaging studies per patient compared with 0.39 (P

119 gles and full-Fourier acquisition (vrfSSFSE) pelvic imaging via a prospective trial performed in the

120 tudies investigating the association between pelvic inflammatory disease (PID) and ovarian cancer ris

121 Pelvic inflammatory disease (PID) is a leading cause of

122 Pelvic inflammatory disease (PID) is an important cause

123 n-for example, cervicitis, endometritis, and pelvic inflammatory disease (PID), including an associat

124 talium as a cause of urethritis, cervicitis, pelvic inflammatory disease (PID), infertility and ectop

125 ars, who presented with a 5-month history of pelvic inflammatory disease and dyspareunia.

126 Repeat infections increased the risk of pelvic inflammatory disease by a further 20% (AHR 1.20,

127 cut-offs of 10ng/mL (for neonatal sepsis and pelvic inflammatory disease) and 30ng/mL (for inflammato

128 he infection (ie urethritis, cervicitis, and pelvic inflammatory disease) and their sex partners.

129 sted positive and those who tested negative (pelvic inflammatory disease, 0.6%; ectopic pregnancy, 0.

130 er in women with one or more positive tests (pelvic inflammatory disease, adjusted hazard ratio [AHR]

131 nd 60% lower in women who were never-tested (pelvic inflammatory disease, AHR 0.33 [0.31-0.35]; ectop

132 otein (CRP)-a biomarker for neonatal sepsis, pelvic inflammatory disease, and inflammatory bowel dise

133 thritis in men and cervicitis, endometritis, pelvic inflammatory disease, and possibly preterm birth,

134 s sequelae of chlamydial infection in women: pelvic inflammatory disease, ectopic pregnancy, and tuba

135 y in the risk of reproductive complications (pelvic inflammatory disease, ectopic pregnancy, and tuba

136 nd emergency department) with a diagnosis of pelvic inflammatory disease, ectopic pregnancy, or tubal

137 an result in debilitating conditions such as pelvic inflammatory disease, infertility, and blindness.

138 rovoke a large inflammatory response and, in pelvic inflammatory disease, this response leads to the

139 d cases and of chlamydial morbidity, such as pelvic inflammatory disease.

140 able mass due to hemihaemato(metro)colpos or pelvic inflammatory disease.

141 osed infection further increased the risk of pelvic inflammatory disease.

142 vate insurance, patients with severe head or pelvic injuries, and those who died during hospitalizati

143 transverse, posterior sagittal diameters of pelvic inlet, the plane of greatest diameter, the plane

144 nteroposterior including three conjugates of pelvic inlet, transverse, posterior sagittal diameters o

145 t remains in the pelvic area and is called a pelvic kidney.

146 We evaluated the efficacy of a pelvic lead shield and a novel surgical cap in reducing

147 The use of a pelvic lead shield and the cap reduced significantly the

148 ed pathologic LN uptake in 4 patients at the pelvic level, in 5 at the abdominal level, in 13 at both

149 T before radical prostatectomy with extended pelvic LN dissection.

150 to reduce or eliminate the need for extended pelvic LN dissections (ePLND).

151 a, before radical prostatectomy and extended pelvic lymph node (LN) dissection, with histopathology a

152 dding sentinel node biopsy (SNB) to extended pelvic lymph node dissection (ePLND) remains controversi

153 tification of the fluorescent lymph nodes, a pelvic lymph node dissection was completed with robotic

154 otherapy followed by radical cystectomy with pelvic lymph node dissection, which disclosed residual h

155 regard to delineation of local recurrence or pelvic lymph node metastasis in selected patients; the l

156 the perivesical fat and involving two of 20 pelvic lymph nodes (pT3N2).

157 -risk cT1b-c to cT2a (with no involvement of pelvic lymph nodes and no clinical evidence of metastati

158 nst Cancer TNM 1997), with no involvement of pelvic lymph nodes and no clinical evidence of metastati

159 that included both the prostate bed and the pelvic lymph nodes were contoured on the CT dataset of t

160 Sentinel-lymph-node mapping with complete pelvic lymphadenectomy was done in 340 patients and para

161 and sentinel-lymph-node mapping followed by pelvic lymphadenectomy with or without para-aortic lymph

162 ssisted radical prostatectomy with bilateral pelvic lymphadenectomy.

163 node measured up to 5 mm, and no additional pelvic lymphadenopathy was identified.

164 Pelvic magnetic resonance (MR) imaging is currently the

165 th normalisation to prostate gland volume on pelvic magnetic resonance imaging (MRI) and have correla

166 aphy integrated with Computed Tomography and pelvic Magnetic Resonance, which showed rapid and diffus

167 y: 1,182 breast cancer, 262 melanoma, and 64 pelvic malignancies (prostate, cervix, penis, vulva).

168 nic bowel dysfunction after radiotherapy for pelvic malignancies.

169 to suspect this syndrome in a female with a pelvic mass and absence of homolateral kidney.

170 Concurrently, his previously obtained pelvic mass biopsy sample was sent for panel-based genom

171 nosis and to eliminate other etiologies like pelvic mass or thrombosis.

172 e underwent palliative radiation to the left pelvic mass to relieve symptoms of pain and leg edema an

173 peritoneal lymphadenopathy and a large right pelvic mass with possible rectal wall invasion consisten

174 Two years later, he developed a left pelvic mass.

175 performed at another hospital had revealed a pelvic mass; therefore, this patient had been referred t

176 d results in the obstetrically most adequate pelvic morphology during the time of maximum female fert

177 eometric morphometrics to analyze changes in pelvic morphology from late fetal stages to adulthood in

178 spite this seeming lack of change in average pelvic morphology, we show that humans have evolved a co

179 nsible for sex-specific differences in adult pelvic morphology.

180 In this study, pelvic MR examinations including an IVIM sequence were p

181 girls (age range, 13-17 years) who underwent pelvic MR imaging in 2006-2015.

182 Pelvic MRI and CT images are interchangeable in retrospe

183 In conclusion, pelvic MRI image is a feasible and reproducible method f

184 A pelvic MRI revealed a mass including hyperintense areas

185 h inflammatory bowel diseases, who underwent pelvic MRI-DIXON and CT scan within one year, were inclu

186 46 patients, screened to exclude those with pelvic muscle and organ pain, uniformly had clinical evi

187 , the clinician should initiate unsupervised pelvic muscle exercises and lifestyle modifications appr

188 We utilized bladder-pelvic nerve preparations to characterize bladder affere

189 afferents from the bladder (primarily in the pelvic nerve) and the urethra (in the pudendal and pelvi

190 nerve) and the urethra (in the pudendal and pelvic nerves) to maintain continence or initiate mictur

191 tecture offers a new framework to understand pelvic neurophysiology as well as development and evolut

192 Pelvic nodal and extrapelvic metastatic disease on (68)G

193 patients proceeded to prostatectomy (7 with pelvic nodal dissection).

194 r >/= 2 years (nonmetastatic); prostate (+/- pelvic node) radiotherapy was encouraged for men without

195 of 102 in the prostatic fossa, 41 of 102 in pelvic nodes, and 23 of 102 distantly.

196 survivors of childhood cancer not exposed to pelvic or cranial radiotherapy.

197 ntral venous catheter placement, presence of pelvic or lower extremity fractures, and major surgery),

198 dominal level, and in 46 at the abdominal or pelvic or other sites.

199 are 3-year rates of cancer recurrence in the pelvic or perineal area (locoregional recurrence) and su

200 gical site [abdominal/pelvic vs nonabdominal/pelvic]: OR, 2.54, 95% CI, 1.67-3.89; and age [in years]

201 d women serving as controls who did not have pelvic organ prolapse (n = 15338).

202 to 65 years at baseline with a diagnosis of pelvic organ prolapse (n = 5130) compared with birth yea

203 Mesh, a synthetic graft, has been used in pelvic organ prolapse (POP) repair and stress urinary in

204 t exfoliation syndrome risk in patients with pelvic organ prolapse (without exfoliation syndrome hist

205 rformed to determine the association between pelvic organ prolapse and exfoliation syndrome in women

206 the exfoliation syndrome risk in women with pelvic organ prolapse compared with those without pelvic

207 en aged 30 to 65 years at baseline who had a pelvic organ prolapse diagnosis compared with controls d

208 ion syndrome was more frequent in women with pelvic organ prolapse in the Utah Population Database, a

209 Pelvic organ prolapse is a common connective tissue diso

210 icipant-reported prolapse symptoms (i.e. the Pelvic Organ Prolapse Symptom Score [POP-SS]) and condit

211 outcome was self-reported prolapse symptoms (Pelvic Organ Prolapse Symptom Score [POP-SS]) at 2 years

212 association between exfoliation syndrome and pelvic organ prolapse using the Utah Population Database

213 surgery for stress urinary incontinence and pelvic organ prolapse using transvaginal mesh.

214 Pelvic organ prolapse was associated with a 1.56-fold in

215 ndrome (exfoliation of the lens capsule) and pelvic organ prolapse was investigated as part of the Ut

216 ontinence (11%), non-injury wounds (9%), and pelvic organ prolapse were also prevalent.

217 ditions with altered ECM metabolism, such as pelvic organ prolapse, may share common biological pathw

218 of concomitant conditions, such as advanced pelvic organ prolapse, that may require referral.

219 c organ prolapse compared with those without pelvic organ prolapse.

220 Pelvic organs exhibit neural crosstalk by convergence of

221 layer, which provides structural support for pelvic organs.

222 t diameter, the plane of least diameter, and pelvic outlet were measured.

223 These species, deficient in IC pelvic pain (DIPP), were further evaluated by Receiver-o

224 Children usually have progressive pelvic pain after menarche, palpable mass due to hemihae

225 (26 of 31 patients) in the context of acute pelvic pain and 92.6% (25 of 27 patients), 88.9% (24 of

226 necological disorder, associated with severe pelvic pain and reduced fertility; however, its molecula

227 oms of endometriosis are chronic intolerable pelvic pain and subfertility or infertility, which profo

228 lammatory condition in women that results in pelvic pain and subfertility, and has been associated wi

229 inical response with respect to nonmenstrual pelvic pain at 3 months.

230 e in improving dysmenorrhea and nonmenstrual pelvic pain during a 6-month period in women with endome

231 2 of 27 patients) in the context of subacute pelvic pain for readers 1, 2, and 3, respectively.

232 es, suggesting that the microbiome modulates pelvic pain in IC.

233 tension-type headache was 4% (2-9); chronic pelvic pain or prostatitis was 11% (8-17); and fibromyal

234 It can exhibit acute pelvic pain shortly after menarche and may show non-spec

235 isorders(MHD) in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) have been widely studied.

236 inical response with respect to nonmenstrual pelvic pain was 50.4% in the lower-dose elagolix group a

237 ith respect to dysmenorrhea and nonmenstrual pelvic pain were sustained at 6 months.

238 All patients with acute or subacute pelvic pain who were undergoing MR examination for the e

239 important causes of intestinal obstruction, pelvic pain, and female infertility.

240 syndromes irritable bowel syndrome, chronic pelvic pain, and fibromyalgia were assessed by questionn

241 plays a central role in the pathogenesis of pelvic pain, one of the core symptoms of endometriosis.

242 ndent condition that causes dysmenorrhea and pelvic pain.

243 as therapeutic targets for treating chronic pelvic pain.

244 one-year history of dysmenorrhea and cyclic pelvic pain.

245 have an adnexal mass with acute or subacute pelvic pain.

246 % of women and is associated with persistent pelvic pain.

247 e of dorsal root ganglia neurons to decrease pelvic pain; (iv) decreases proinflammatory, estrogen-do

248 of multiple leiomyomas in the abdominal and pelvic peritoneum.

249 One hour after injection, a pelvic PET/CT scan was acquired for preoperative SLN map

250 curate pseudo-CT images and reduces error in pelvic PET/MRI attenuation correction compared with stan

251 We compared the effectiveness of pelvic physiotherapy (PPT) vs standard medical care (SMC

252 eported having had progressive constipation, pelvic pressure, and narrow-caliber stools for 2 months.

253 on, vaginal brachytherapy is as effective as pelvic radiation therapy at preventing vaginal recurrenc

254 or cervical stroma invasion may benefit from pelvic radiation to prevent pelvic recurrence.

255 sentation, tumor height, clinical stage, and pelvic radiation.

256 e women were more likely to receive adjuvant pelvic radiotherapy (34.3% v 31.3%) and brachytherapy (3

257 SC consisted of pelvic radiotherapy 5 x 5 Gy in 1 week, early surgery an

258 eriencing chronic intestinal syndromes after pelvic radiotherapy for decades, yet the evidence to sup

259 ry advice to follow a high-fiber diet during pelvic radiotherapy resulted in reduced gastrointestinal

260 nal OS among patients not receiving previous pelvic radiotherapy was 24.5 months versus 16.8 months (

261 95% CI, 1.9 to 6.8; P < .001) and abdominal/pelvic radiotherapy within 5 years of cancer diagnosis (

262 efore the first dose of study drug, previous pelvic radiotherapy, or previous treatment with poly (AD

263 rointestinal toxicity in patients undergoing pelvic radiotherapy.Patients were randomly assigned to l

264 uently developed metastatic disease or local pelvic recurrence after radical treatment that was not a

265 R0 resection of the pelvic recurrence is the most significant factor affecti

266 PFS, OS, and pelvic recurrence nomograms had bootstrap-corrected conc

267 may benefit from pelvic radiation to prevent pelvic recurrence.

268 Primary retroperitoneal sarcomas in the pelvic region are extremely rare.

269 xtraluminal biliary stent migration into the pelvic region that caused intestinal perforation.

270 s suggested a retroperitoneal sarcoma in the pelvic region with metastases to the liver.

271 , additional sites were found, mainly in the pelvic region.

272 t and left para-aortic and common iliac) and pelvic (right and left external iliac and obturator) LN

273 Restriction and autotomy of the tail limits pelvic rotation, which reduces femur retraction and decr

274 ked with upper body rotations that countered pelvic rotation.

275 rate that even if early hominins walked with pelvic rotations 50% larger than humans, they may have a

276 RT for retroperitoneal or pelvic sarcoma is controversial, and few studies have co

277 are patients with primary retroperitoneal or pelvic sarcoma treated during 2003-2011.

278 RT to surgery for primary retroperitoneal or pelvic sarcoma was associated with improved LRFS, althou

279 nic pouch was the only independent factor of pelvic sepsis (odds ratio = 1.757; 95% confidence interv

280 A temporary ileostomy may reduce the risk of pelvic sepsis after anastomotic dehiscence.

281 Pelvic sepsis developing after redo ileal pouch surgery

282 Pelvic sepsis is one of the major complications after re

283 The rate of pelvic sepsis was 17.1% (80/469) and was similar between

284 Primary endpoint was postoperative pelvic sepsis within 30 postoperative days, including an

285 Axial and pelvic skeletal involvement is greater than previously r

286 6% of patients, including 47% with axial and pelvic skeletal involvement), kidneys (81.3%), and centr

287 ceived diagnostic capability when evaluating pelvic structures.

288 ions compared with limited axial (lumbar and pelvic) studies, especially in the thoracic spine and th

289 dered in those undergoing major abdominal or pelvic surgery with high-risk features.

290 The patient had no prior pelvic surgery.

291 Location of pelvic tumor was the major inferior disease-specific pro

292 The RT group had a higher percentage of pelvic tumors (P = 0.03) and a different distribution of

293 rainage such as breast cancer, melanoma, and pelvic tumors.

294 Her pelvic ultrasound demonstrated a normal- sized uterus wi

295 MRI, breast MRI, mammography, abdominal and pelvic ultrasound, and colonoscopy) was introduced at th

296 dronephrosis and failure to develop a patent pelvic-ureteric junction.

297 yses of epithelial cell types present in the pelvic urethra and regions of the bladder.

298 region with a dilated left ovarian vein and pelvic varicose veins.

299 A kinship between cranial and pelvic visceral nerves of vertebrates has been accepted

300 95% CI, 1.59-12.56; surgical site [abdominal/pelvic vs nonabdominal/pelvic]: OR, 2.54, 95% CI, 1.67-3